IRPSX
Price
$10.94
Change
-$0.22 (-1.97%)
Updated
May 21 closing price
Net Assets
284.94M
VIVIX
Price
$66.27
Change
-$1.22 (-1.81%)
Updated
May 21 closing price
Net Assets
183.65B
Interact to see
Advertisement

IRPSX vs VIVIX

Header iconIRPSX vs VIVIX Comparison
Open Charts IRPSX vs VIVIXBanner chart's image
VY® T. Rowe Price Equity Income S
Price$10.94
Change-$0.22 (-1.97%)
VolumeN/A
Net Assets284.94M
Vanguard Value Index I
Price$66.27
Change-$1.22 (-1.81%)
VolumeN/A
Net Assets183.65B
IRPSX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IRPSX vs. VIVIX commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRPSX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. IRPSX (285M). VIVIX pays higher dividends than IRPSX: VIVIX (2.35) vs IRPSX (1.68). IRPSX was incepted earlier than VIVIX: IRPSX (36 years) vs VIVIX (27 years). IRPSX (0.89) is less costly to investors than VIVIX (0.04). IRPSX is a more actively managed with annual turnover of: 21.00 vs. VIVIX (9.00). IRPSX has a lower initial minimum investment than VIVIX: IRPSX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 6.23 vs. IRPSX (1.10). VIVIX return over 5 years is better than : 78.42 vs. IRPSX (57.04).
IRPSXVIVIXIRPSX / VIVIX
Total Expense Ratio0.860.042,150%
Annual Report Gross Expense Ratio0.890.042,225%
Fund Existence36 years27 years-
Gain YTD4.3972.240196%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets285M184B0%
Annual Yield % from dividends1.682.3571%
Returns for 1 year1.106.2318%
Returns for 3 years3.1926.4212%
Returns for 5 years57.0478.4273%
Returns for 10 years-17.17100.95-17%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVCT0.08N/A
+6.37%
Provectus Biopharmaceuticals, Inc.
HELFY2.97N/A
N/A
Hellofresh SE
ESLOY146.56-0.52
-0.35%
EssilorLuxottica
SWRAY8.63-0.05
-0.58%
Swire Pacific Ltd.
CLPBY9.64-0.12
-1.19%
Coloplast AS